Microdialysis probe technology provides access to tissue interstitium for either sampling of diffusible tissue constituents or delivery of bioactive substances. However, the relationship of the probe perfusate concentrations to their tissue counterparts is a complex function of solute molecular weight, solute physicochemical properties, tissue properties, probe membrane properties, probe geometry, perfusion rate, and the trauma of probe insertion into the tissue. These dependencies are being studied in order to improve the quantitative usefulness of the technology. Applications in the brain are being pursued in connection with Parkinson's disease, AIDS, alcoholism, and studies of drugs of abuse. Other applications involve various normal tissues and tumors. Endogenous solutes of interest include dopamine and quinolinic acid. Examples of exogenous substances employed are Zidovudine (AZT), ethanol and cocaine. Mathematical modeling is used to describe diffusive and convective solute transport within the probe and in surrounding tissue. Required knowledge of physical properties of the probes, such as diffusive and convective permeabilities of probe membranes, can be determined under well-characterized conditions in vitro. Validation experiments in animals (rats and primates) involve quantitative autoradiography, histology, and chemical assay of tissue surrounding the probe, as well as measurement of probe perfusate concentrations.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Intramural Research (Z01)
Project #
1Z01OD010276-04
Application #
6548613
Study Section
(BEPS)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Office of the Director, NIH
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Chefer, Vladimir I; Zapata, Agustin; Shippenberg, Toni S et al. (2006) Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. J Neurosci Methods 155:187-93
Benjamin, Ramsis K; Hochberg, Fred H; Fox, Elizabeth et al. (2004) Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposium. Neuro Oncol 6:65-74
Tang, Amanda; Bungay, Peter M; Gonzales, Rueben A (2003) Characterization of probe and tissue factors that influence interpretation of quantitative microdialysis experiments for dopamine. J Neurosci Methods 126:1-11
Bungay, Peter M; Newton-Vinson, Paige; Isele, Wanda et al. (2003) Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J Neurochem 86:932-46
Fox, Elizabeth; Bungay, Peter M; Bacher, John et al. (2002) Zidovudine concentration in brain extracellular fluid measured by microdialysis: steady-state and transient results in rhesus monkey. J Pharmacol Exp Ther 301:1003-11
Sun, H; Bungay, P M; Elmquist, W F (2001) Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain. J Pharmacol Exp Ther 297:991-1000
Ludvig, N; George, M A; Tang, H M et al. (2001) Evidence for the ability of hippocampal neurons to develop acute tolerance to ethanol in behaving rats. Brain Res 900:252-60
Bungay, P M; Dedrick, R L; Fox, E et al. (2001) Probe calibration in transient microdialysis in vivo. Pharm Res 18:361-6